Literature DB >> 17633024

TRAFs in RANK signaling.

Bryant G Darnay1, Arnaud Besse, Ann T Poblenz, Betty Lamothe, Jörg J Jacoby.   

Abstract

Members of the tumor necrosis factor (TNF) family govern many diverse physiological and cellular responses including cellular proliferation, differentiation, and apoptosis. Ligands of this family interact through a distinct set of specific receptors that lack enzymatic activity and therefore are dependent on the association of adaptor molecules. One receptor/ligand pair known as receptor activator of nuclear factor-kappa B (RANK) and RANK ligand (RANKL) regulates bone remodeling, mammary gland development, and lymph node organogenesis. RANK interacts with five members of the TNF receptor-associated factor (TRAF) family, of which TRAF6 is indispensable for its signaling capability. An accumulation of evidence from various research laboratories indicates TRAFs, but more importantly TRAF6, is the key to understanding how RANKL links cytoplasmic signaling to the nuclear transcriptional program.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17633024     DOI: 10.1007/978-0-387-70630-6_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  33 in total

Review 1.  Computational prediction of protein hot spot residues.

Authors:  John Kenneth Morrow; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Novel therapeutic targets in myeloma bone disease.

Authors:  S L Webb; C M Edwards
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

3.  The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.

Authors:  Jingjing Lin; Daekee Lee; Yongwon Choi; Soo Young Lee
Journal:  Sci Signal       Date:  2015-06-02       Impact factor: 8.192

Review 4.  TRAF6 activation in multiple myeloma: a potential therapeutic target.

Authors:  Hong Liu; Samantha Tamashiro; Stavroula Baritaki; Manuel Penichet; Youhua Yu; Haiming Chen; James Berenson; Benjamin Bonavida
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-03-21

5.  Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.

Authors:  Yuvaraj Sambandam; Purushoth Ethiraj; Jessica D Hathaway-Schrader; Chad M Novince; Ezhil Panneerselvam; Kumaran Sundaram; Sakamuri V Reddy
Journal:  J Cell Physiol       Date:  2018-03-06       Impact factor: 6.384

Review 6.  Functions of nuclear factor kappaB in bone.

Authors:  Brendan F Boyce; Zhenqiang Yao; Lianping Xing
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

7.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

Review 8.  Regulation of Akt signaling activation by ubiquitination.

Authors:  Wei-Lei Yang; Ching-Yuan Wu; Juan Wu; Hui-Kuan Lin
Journal:  Cell Cycle       Date:  2010-02-01       Impact factor: 4.534

Review 9.  Tumor-stroma co-evolution in prostate cancer progression and metastasis.

Authors:  Sajni Josson; Yasuhiro Matsuoka; Leland W K Chung; Haiyen E Zhau; Ruoxiang Wang
Journal:  Semin Cell Dev Biol       Date:  2009-12-03       Impact factor: 7.727

Review 10.  Inflammation, cancer, and bone loss.

Authors:  Yousef Abu-Amer
Journal:  Curr Opin Pharmacol       Date:  2009-07-02       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.